Zenrelia: A new treatment to elevate care in canine allergic and atopic dermatitis (LVS25) Bundle recognition of these changes may

recognition of these changes may provide an opportunity for diagnosis prior to the onset of severe clinical signs

Cats are really not small dogs – know the differences in their diabetes Explore consult considerations and monitoring options How to shape discussions and recommendations within our remit

and discover how to position their practice to attract the right buyer

MANZCVS Veterinary Ophthalmologist

induction drugs and inhalant drugs cause CNS depression and most cause some degree of dose-dependent physiologic dysfunction

Zenrelia: A new treatment to elevate care in canine allergic and atopic dermatitis (LVS25) Bundle recognition of these changes mayPresented at London Vet Show 2025. 20 Nov 2025 11: 30 12: 30 Gallery Suite 22 This session will focus on your treatment targets when treating atopic patients, data from the Zenrelia clinical trials and real world experience with Zenrelia from some of the UKs leading dermatologists. Learn about Zenrelia (ilunocitinib), Elancos new once daily JAK inhibitor for the treatment of canine allergic and atopic dermatitis which brings 45% more itchy dogs back